| Name: | Aripiprazole N Isomer |
| Catalogue No. | VE006778 |
| CAS No. | 1797983-65-3 |
| Molecular Formula | C23H27Cl2N3O2 |
| Molecular Weight | 448.39 g/mol |
| Status | In-Stock |
| IUPAC Name | 1-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-7-hydroxy-3,4-dihydro quinolin-2(1H)-one |
| Description | Aripiprazole N Isomer(CAS No: 1797983-65-3)or 1-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-7-hydroxy-3,4-dihydro quinolin-2(1H)-one. it is used in the treatment of schizophrenia and bipolar I disorder. it is a dopamine partial agonist, it also has a substantial binding affinity for the serotonin 5HT2A receptor. |
| References | Citrome, Leslie. “A Review of Aripiprazole in the Treatment of Patients with Schizophrenia or Bipolar I Disorder.” Neuropsychiatric Disease and Treatment, vol. 2, no. 4, Dec. 2006, pp. 427–43, www.ncbi.nlm.nih.gov/pmc/articles/PMC2671949/. Montastruc, François, et al. “Association of Aripiprazole with the Risk for Psychiatric Hospitalization, Self-Harm, or Suicide.” JAMA Psychiatry, vol. 76, no. 4, Apr. 2019, p. 409, https://doi.org/10.1001/jamapsychiatry.2018.4149. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
